NanoFUSE Biologics

NanoFUSE Biologics is a biotechnology company that specializes in a patented synthetic bioactive ceramic-based osteobiologic technology known as 45S5 bioglass, combined with demineralized bone matrix (DBM). It is the first and only FDA-approved product that integrates these two components into a single osteobiologic product, designed to promote new bone formation and healing in bony voids or gaps. The core product, NanoFUSE, works by releasing beneficial ions when mixed with body fluids, which stimulates cell activity and supports bone growth within 24 hours. Its advantages include anti-microbial properties, customizable formulations, and a proven clinical track record in spinal fusion and bone healing. NanoFUSE Biologics primarily serves the medical and surgical markets in the United States, focusing on applications that require effective bone regeneration and fusion.

• Employees2
• Founded2018